The Alliance is seeing a significant increase in women diagnosed with sexually transmitted infections (STIs) in all three counties, with chlamydia being one of the most common STIs diagnosed in young women. However, most do not experience symptoms, and if left undiagnosed and untreated, can cause permanent damage to a woman’s reproductive system.
In accordance with National Committee of Quality Assurance (NCQA) guidelines, the Alliance will be reporting rates for the Chlamydia Screening in Women (CHL) measure to the Department of Health Care Services (DHCS) for 2020 (measurement year 2019). This measure looks at women 16 – 24 years old, who are sexually active, and received at least one test for chlamydia in 2019. The Alliance has also added this as an Exploratory Measure for the 2020 Care-Based Incentive Program.
The United States Preventive Services Task Force (USPSTF) recommends annual chlamydia and gonorrhea screenings should be performed on women 25 and older who are considered at risk. Chlamydia, Syphilis, HIV, and Hepatitis B screenings should be performed on all pregnant women, and Gonorrhea screening for pregnant women at risk.
HIV screenings should be performed on everyone, regardless of gender, between the ages of 13 – 64 years of age. Populations considered high risk are men who have sex with other men (MSM). MSM typically have a higher rate of STIs and should be tested for the broader range of STIs.
As chlamydia rates are on the rise in all three regions, have the conversation, give the screening – reduce the stigma, and talk about STI’s. STI screenings are essential for early diagnosis and treatment. Review the Chlamydia and Gonorrhea Provider Portal Report for your sexually active patients that may need to be seen by December 31st to be compliant for this measure.
|Chlamydia||87110, 87270, 87320, 87490, 87491, 87492|
|Gonorrhea||87590, 87591, 87592, 87850|
|Syphilis||86592, 86593, 0065U|
|HIV||86701, 86702, 86703, 87534-87539, 87389-87391, 86689, 87901,
87903, 87904, 87906, 87806